Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Delta-like 4 is required for pulmonary vascular arborization and alveolarization in the developing lung
Sheng Xia, Heather L. Menden, Nick Townley, Sherry M. Mabry, Jeffrey Johnston, Michael F. Nyp, Daniel P. Heruth, Thomas Korfhagen, Venkatesh Sampath
Sheng Xia, Heather L. Menden, Nick Townley, Sherry M. Mabry, Jeffrey Johnston, Michael F. Nyp, Daniel P. Heruth, Thomas Korfhagen, Venkatesh Sampath
View: Text | PDF
Research Article Pulmonology Vascular biology

Delta-like 4 is required for pulmonary vascular arborization and alveolarization in the developing lung

  • Text
  • PDF
Abstract

The molecular mechanisms by which endothelial cells (ECs) regulate pulmonary vascularization and contribute to alveolar epithelial cell development during lung morphogenesis remain unknown. We tested the hypothesis that delta-like 4 (DLL4), an EC Notch ligand, is critical for alveolarization by combining lung mapping and functional studies in human tissue and DLL4-haploinsufficient mice (Dll4+/lacz). DLL4 expressed in a PECAM-restricted manner in capillaries, arteries, and the alveolar septum from the canalicular to alveolar stage in mice and humans. Dll4 haploinsufficiency resulted in exuberant, nondirectional vascular patterning at E17.5 and P6, followed by smaller capillaries and fewer intermediate blood vessels at P14. Vascular defects coincided with polarization of lung EC expression toward JAG1-NICD-HES1 signature and decreased tip cell-like (Car4) markers. Dll4+/lacZ mice had impaired terminal bronchiole development at the canalicular stage and impaired alveolarization upon lung maturity. We discovered that alveolar type I cell (Aqp5) markers progressively decreased in Dll4+/lacZ mice after birth. Moreover, in human lung EC, DLL4 deficiency programmed a hypersprouting angiogenic phenotype cell autonomously. In conclusion, DLL4 is expressed from the canalicular to alveolar stage in mice and humans, and Dll4 haploinsufficiency programs dysmorphic microvascularization, impairing alveolarization. Our study reveals an obligate role for DLL4-regulated angiogenesis in distal lung morphogenesis.

Authors

Sheng Xia, Heather L. Menden, Nick Townley, Sherry M. Mabry, Jeffrey Johnston, Michael F. Nyp, Daniel P. Heruth, Thomas Korfhagen, Venkatesh Sampath

×

Figure 2

DLL4 lung mapping using the Dll4+/lacZ reporter mice.

Options: View larger image (or click on image) Download as PowerPoint
DLL4 lung mapping using the Dll4+/lacZ reporter mice.
(A) X-gal staining...
(A) X-gal staining on Dll4+/+ and Dll4+/lacZ mouse lungs. Blue color represents lacZ gene expression, which indicates DLL4 expression, and fast red (red) represents nucleus (n = 3). Dll4+/+ samples were used as X-gal negative control. (B) X-gal and EPHB4 IHC (brown) staining on P14 mouse sample shows that DLL4 is not expressed in EPHB4+ cells. The arrow (left panel) points to an intermediate Dll4+ EPHB4– blood vessel, and the arrow (right panel) points to a Dll4– EPHB4+ blood vessel. (C) X-gal and PECAM IHC (brown) staining on P6 mouse lung sample. The black arrows point to the leading EC of blood vessel, and the red arrow points to a capillary branching from a small artery. (D) qRT-PCR showing mouse whole lung Dll4 expression from the canalicular to alveolar stage in WT and Dll4+/lacZ mice. n = 5 mice per group; *P < 0.01, E17.5 DLL4+/+ vs. P4, P14, P28 DLL4+/+ mice; **P < 0.01, E17.5 DLL4+/lacZ versus P4, P14, P28 DLL4+/lacZ mice. Scale bars: 50 μm (A and B); 10 μm (C). Data are shown as mean ± SD throughout. (D) One-way ANOVA with Tukey’s test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts